Dr. Gail Patrice Ishiyama, MD

Dr. Ishiyama practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Ishiyama's NPI, 1639194038, was assigned on July 13, 2006. Dr. Ishiyama graduated from David Geffen School of Medicine at UCLA in 1992. Dr. Ishiyama holds California license G80933.

Dr. Ishiyama's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Ishiyama's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Ishiyama is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Head & Neck Associates. Dmand AI also links Dr. Ishiyama to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ishiyama practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Ishiyama's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Ishiyama is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Ishiyama is licensed in California.

Dmand AI lists lower back pain, migraine and chronic headache and vertigo among the conditions Dr. Ishiyama treats.

CMS data shows 1,323 Medicare services from Dr. Ishiyama across 9 procedure codes in 2024, for 344 Medicare patients. Medicare paid $113,108 for them. Every service was in an office.

CMS counts 344 Medicare patients who saw Dr. Ishiyama in 2024. The largest group is 65 to 74, with 163 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ishiyama's median patient age at 63, with 66% women.

In 2024, Dr. Ishiyama wrote 96 Medicare Part D claims for 36 patients. 94% of them were for generic drugs. CMS names the drug for 54 of them, across 4 drugs with 11 or more claims each, at $3,248 in total drug cost. In 2023, CMS named 86 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Ishiyama for performance year 2024, reported as part of a group. Dr. Ishiyama accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ishiyama as offering telehealth.

Dmand AI links 20 papers to Dr. Ishiyama, published from 2006 to 2025. 2016 was the busiest year, with 4. Dr. Ishiyama has published most often in Otol Neurotol. Dr. Ishiyama's most frequent co-authors are Akira Ishiyama, MD, Ali R. Sepahdari, MD and Jacob Lee Wester, MD.

CMS Open Payments shows 7 general payments to Dr. Ishiyama from 2 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Cochlear Ltd paid the most, $471.

Dr. Ishiyama graduated from David Geffen School of Medicine at UCLA in 1992.

Dr. Ishiyama is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.